Bringing Medical Treatment to Neonatal Patients Across Africa

Primary tabs

Bringing Medical Treatment to Neonatal Patients Across Africa

Medical Technology Transfer and Services to bring low-cost access to neonatal treatment to 10 African countries

tweet me:
The first 28 days of life are when children are most vulnerable to illness. @MTTSLifeKit is bringing low-cost access to #neonatal treatment to 10 African countries: http://bit.ly/2UnQ1p5 #accesstocare @BCtAInitiative
Wednesday, March 6, 2019 - 9:15am

CONTENT: Press Release

HANOI, Vietnam, March 6, 2019 /3BL Media/ – Medical devices designer and manufacturer Medical Technology Transfer and Services (MTTS) has answered the Business Call to Action (BCtA), as the social enterprise commits to delivering access to neonatal treatment for 495,000 low income patients in 10 African countries through the delivery of devices to 200 hospitals. MTTS aims to meet their goal by 2022.

Launched in 2008, BCtA aims to accelerate progress towards the Sustainable Development Goals (SDGs) by challenging companies to develop inclusive business models that engage people with less than US$10 per day in purchasing power (in 2015 dollars) as consumers, producers, suppliers and distributors. It is supported by several international organizations and hosted by the United Nations Development Programme (UNDP).

The first 28 days of life (the neonatal period) is considered to be the time when children are most vulnerable to illness and death due to poor medical care and diseases. The United Nations International Children's Emergency Fund (UNICEF) says that in 2017, about 2.5 million children died in 30 days after birth. This can be seen in West and Central Africa and South Asia, with each region having an estimated 27 deaths per 1,000 live births in 2017, despite the global decline in the neonatal mortality rate.

As the cost of medical devices for neonatal care is a significant contributor to these high mortality rates, MTTS sought to design new medical technologies that would be low cost, washable and reusable for use in the poorest regions, especially in the company’s home country Vietnam. MTTS’ CEO Gregory Dajer explained that after examining global health needs, it was clear that the company’s products were needed in many countries, especially in the African continent.

Dajer said: “We have realised that unfortunately, in some countries in the world, healthcare is a privilege that comes at a cost that some cannot afford. With our devices the poorest people, often the children of those families living on less than US$10 a day, can have access to timely medical care at their local hospitals.”

Based on the need for affordable healthcare, MTTS has signed on to the BCtA as it seeks to participate in the global movement to meet the Sustainable Development Goals (SDGs), with focus placed on SDG 3 and SDG 10. As part of this commitment, low income patients in Nigeria, Zimbabwe, Burkina Faso, Togo, Benin, Senegal, Ghana, Kenya, Uganda and Tanzania will benefit from treatment by 2022.

“Access to healthcare is a crucial part of having a truly developed and inclusive global community, and to resolve this challenge we must use innovative and protean thinking to develop solutions. We are therefore happy to step up to the challenge, and to join the BCtA initiative as we aim to create a world where healthcare can be accessed by all,” said Dajer.

Reflecting on MTTS’ commitment to delivering access to neonatal treatment, Head of the BCtA initiative, Paula Pelaez, said she was pleased that the company will provide devices for African countries that are in need.

“It is important for us to remember that healthcare and the wellbeing of the world’s people are essential parts of the 2030 Agenda for Sustainable Development. Without proper healthcare, development will always be a challenge. This is why MTTS’ model and work is so important, as it will change the lives of people in the 10 countries that will be targeted. I am happy to see their commitment to the BCtA, and I look forward to partnering with them on future endeavours,” she said.

For further information: 

BCtA: aimee.brown@undp.org

Medical Technology Transfer and Services (MTTS): gregory.dajer@mtts-asia.com
 
BCtA membership does not constitute a partnership with its funding and programme partners, UNDP or any UN agency.

About Business Call to Action (BCtA): Launched at the United Nations in 2008, BCtA aims to accelerate progress towards the Sustainable Development Goals (SDGs) by challenging companies to develop inclusive business models that offer the potential for both commercial success and development impact. BCtA is supported by the Dutch Ministry of Foreign Affairs, Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), UK Department for International Development (DFID), and hosted by the United Nations Development Programme (UNDP). For more information, please visit www.businesscalltoaction.org.

About Medical Technology Transfer and Services: MTTS was established in 2004 with the goal of delivering innovative, cost-effective solutions for newborns in need of intensive medical care. The company offers a comprehensive suite of technologies for neonatal care -from CPAP machines that treat respiratory distress syndrome to phototherapy machines that treat neonatal jaundice. These state-of-the-art devices help healthcare professionals to deliver a better quality of healthcare to a growing number of patients, and at a lower cost. For more information, please visit www.mtts-asia.com